© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Black and Latino bisexual adults in this small survey had the lowest confidence in accessing HIV care and prevention services.
Black cisgender people are likelier than whites to be offered services for their partners—but the same isn’t true for Black trans people.
Charles Sanchez is the Mad Hatter of the HIV community, and this is the proof.
Early studies of dapivirine lubricant for anal sex indicate how far the field has come—and how far it still has to go.
UPDATED: Stars of the HIV web series “Merce” release an HIV educational video each day, leading up to a big reveal on February 23.
An HIV prevention roundup
A study finds that long-acting cabotegravir is an effective PrEP option for women.
The Haven empowers Black and Latino LGBTQ people by offering HIV and hepatitis C testing, PrEP and more.
Why HIV and COVID-19 are racial justice issues—and what the Black, Queer+ Center for Liberation is doing about it.
A single dose of the HIV capsid inhibitor reduced viral load in highly treatment-experienced people.
No need to sneak around when booking back-to-back dates. Why not be sex-positive and honest too!
The vaginal ring, approved in Europe, is not yet available in the United States.
Cabotegravir injections and daily Truvada are both highly effective, but some people may find it easier to use the long-acting regimen.
Enrollees in the national Ready, Set, PrEP program can now have their meds delivered via mail at no cost.
Monthly islatravir pills are just one of the long-acting options in the HIV prevention pipeline.
A new CDC model shows the potential power of Undetectable = Untransmittable to curb HIV rates by 2027.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.